Action of caerulein and related substances on gastrointestinal motility of the anaesthetized dog.
D000818:Animals; D001001:Anura; D001285:Atropine / Q000494:pharmacology; D003106:Colon; D004285:Dogs; D004336:Drug Antagonism; D004386:Duodenum; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005765:Gastrointestinal Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007082:Ileum; D008297:Male; D008365:Manometry; D009119:Muscle Contraction; D009130:Muscle, Smooth / Q000187:drug effects; D010455:Peptides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D011708:Pylorus; D012633:Secretin / Q000494:pharmacology; D012867:Skin; D013268:Stimulation, Chemical; D013779:Tetrodotoxin / Q000494:pharmacology
D005765:Gastrointestinal Agents; D006584:Hexamethonium Compounds; D010455:Peptides; D012633:Secretin; D013779:Tetrodotoxin; D001285:Atropine; D010830:Physostigmine; D004837:Epinephrine